Logo image of TMCI

TREACE MEDICAL CONCEPTS INC (TMCI) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:TMCI - US89455T1097 - Common Stock

2.65 USD
-0.05 (-1.85%)
Last: 1/15/2026, 8:21:01 PM
2.65 USD
0 (0%)
After Hours: 1/15/2026, 8:21:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
TMCI revenue by date.TMCI revenue by date.
141.8M
50.21%
187.118M
31.96%
209.357M
11.89%
216.16M
3.25%
218.31M
0.99%
235.45M
7.85%
364.85M
54.96%
EBITDA
YoY % growth
TMCI ebitda by date.TMCI ebitda by date.
-32.67M
-106.64%
-46.076M
-41.03%
-47.269M
-2.59%
-6.926M
85.35%
-5.185M
25.14%
-4.641M
10.49%
34.374M
840.66%
EBIT
YoY % growth
TMCI ebit by date.TMCI ebit by date.
-34.8M
-110.91%
-51.428M
-47.78%
-55.688M
-8.28%
-58.269M
-4.64%
-51.801M
11.10%
-48.736M
5.92%
-21.726M
55.42%
Operating Margin
TMCI operating margin by date.TMCI operating margin by date.
-24.54%-27.48%-26.60%-26.96%-23.73%-20.70%-5.95%
EPS
YoY % growth
TMCI eps by date.TMCI eps by date.
-0.77
-87.80%
-0.81
-5.19%
-0.85
-4.94%
-0.81
4.70%
-0.87
-7.03%
-0.84
2.82%
-0.26
69.73%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.15
-1,430.00%
-0.25
1.40%
-0.26
7.11%
-0.24
7.15%
-0.13
17.78%
-0.24
0.69%
-0.24
7.84%
-0.20
17.61%
-0.02
83.78%
Revenue
Q2Q % growth
62.516M
-9.01%
53.091M
0.99%
48.248M
1.82%
51.228M
2.02%
67.579M
8.10%
59.833M
12.70%
54.519M
13.00%
59.247M
15.65%
79.03M
16.94%
EBITDA
Q2Q % growth
3.394M
-58.69%
-3.177M
75.78%
-4.251M
64.39%
-2.644M
66.36%
5.936M
74.90%
-2.071M
34.83%
-4.763M
-12.06%
-3.325M
-25.75%
5.182M
-12.70%
EBIT
Q2Q % growth
-8.622M
-4,126.25%
-14.154M
9.17%
-15.227M
10.29%
-13.982M
10.81%
-6.118M
29.04%
-14.719M
-3.99%
-15.932M
-4.64%
-12.974M
7.21%
-4.508M
26.31%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.26
-4.00%
-0.290.038.96%
Q2 2025
Q2Q % growth
-0.28
3.45%
-0.290.014.79%
Q1 2025
Q2Q % growth
-0.25
16.67%
-0.310.0618.69%
Q4 2024
Q2Q % growth
-0.01
90.00%
-0.040.0374.58%
Q3 2024
Q2Q % growth
-0.25
10.71%
-0.280.039.78%
Q2 2024
Q2Q % growth
-0.29
-45.00%
-0.300.011.96%
Q1 2024
Q2Q % growth
-0.30
-30.43%
-0.310.012.89%
Q4 2023
Q2Q % growth
-0.10
-25.00%
-0.09-0.01-10.69%
Q3 2023
Q2Q % growth
-0.28
-27.27%
-0.27-0.01-5.00%
Q2 2023
Q2Q % growth
-0.20
35.48%
-0.240.0417.73%
Q1 2023
Q2Q % growth
-0.23
-43.75%
-0.230.001.24%
Q4 2022
Q2Q % growth
-0.08
33.33%
-0.140.0643.98%
Q3 2022
Q2Q % growth
-0.22
-83.33%
-0.290.0724.98%
Q2 2022
Q2Q % growth
-0.31
-210.00%
-0.21-0.10-48.25%
Q1 2022
Q2Q % growth
-0.16
-128.57%
-0.210.0522.54%
Q4 2021
Q2Q % growth
-0.12 -0.01-0.11-2,252.94%
Q3 2021
Q2Q % growth
-0.12 -0.120.001.96%
Q2 2021
Q2Q % growth
-0.10 -0.120.0218.30%
Q1 2021
Q2Q % growth
-0.07 -0.06-0.01-14.38%
TMCI Yearly EPS VS EstimatesTMCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6 -0.8
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
50.214M
11.37%
50.726M-512K-1.01%
Q2 2025
Q2Q % growth
47.387M
6.60%
47.994M-607K-1.26%
Q1 2025
Q2Q % growth
52.57M
2.86%
53.111M-541K-1.02%
Q4 2024
Q2Q % growth
68.708M
10.44%
68.5M208K0.30%
Q3 2024
Q2Q % growth
45.086M
10.62%
44.354M732K1.65%
Q2 2024
Q2Q % growth
44.455M
5.96%
43.86M595K1.36%
Q1 2024
Q2Q % growth
51.108M
21.12%
50.046M1.062M2.12%
Q4 2023
Q2Q % growth
62.212M
25.00%
61.761M451K0.73%
Q3 2023
Q2Q % growth
40.758M
23.28%
42.896M-2.138M-4.98%
Q2 2023
Q2Q % growth
41.953M
39.98%
41.665M288K0.69%
Q1 2023
Q2Q % growth
42.195M
45.25%
40.03M2.165M5.41%
Q4 2022
Q2Q % growth
49.77M
48.83%
45.645M4.125M9.04%
Q3 2022
Q2Q % growth
33.06M
52.91%
30.668M2.392M7.80%
Q2 2022
Q2Q % growth
29.97M
45.13%
29.206M764K2.62%
Q1 2022
Q2Q % growth
29.05M
55.26%
26.554M2.496M9.40%
Q4 2021
Q2Q % growth
33.44M
38.76%
32.912M528K1.60%
Q3 2021
Q2Q % growth
21.62M
51.51%
21.42M200K0.93%
Q2 2021
Q2Q % growth
20.65M
166.80%
19.312M1.338M6.93%
Q1 2021
Q2Q % growth
18.71M
66.16%
19.142M-432K-2.26%
TMCI Yearly Revenue VS EstimatesTMCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -8882.04% 0% 1.55%
Revenue0% -21.08% 0% -6.67%